Memorial Hospital Research Laboratories

The Charles Rudin Lab

Research

Charles M. Rudin, MD, PhD
Charles M. Rudin, MD, PhD

Physician-scientist Charles M. Rudin, Chief of the Thoracic Oncology Service, leads research that focuses on the development and testing of novel therapeutic approaches to lung cancer in preclinical models including patient-derived xenografts. These studies are integrated with early phase clinical trials.

The Charles Rudin Lab

Publications

People

Charles M. Rudin, MD, PhD

Charles M. Rudin, MD, PhD

  • Physician-scientist Charles Rudin focuses on the development and testing of novel therapeutic approaches to lung cancer in preclinical models.
  • MD, PhD, University of Chicago Pritzker School of Medicine
[email protected]
Email Address
View physician profile
Physician profile

Members

Triparna Sen, PhD
Triparna Sen

Assistant Attending/Lab Co-Director

Viola Allaj
Viola Allaj

Senior Research Technician

Metamia Ciampricotti
Metamia Ciampricotti

Research Fellow

Corrin Wohlhieter
Corrin Wohlhieter

Graduate Student

Nisarg Shah
Nisarg Shah

Senior Research Assistant/Lab Manager

Joseph Chan
Joseph Chan

Thoracic Oncology Fellow

Andrew Chow
Andrew Chow

Assistant Attending, Thoracic Oncology Service

Emily Costa

Graduate Student

W. Victoria Lai
Victoria Lai

Assistant Attending, Thoracic Oncology Service

Michael Offin, MD
Michael Offin

Assistant Attending, Thoracic Oncology Service

Hirokazu Taniguchi
Hirokazu Taniguchi

Research Fellow

Fathema Uddin
Fathema Uddin

Research Technician

Álvaro  Quintanal  Villalonga
Álvaro Quintanal Villalonga

Research Fellow

Rebecca Caeser
Rebecca Caeser

Research Fellow

Parvathy Manoj
Parvathy Manoj

Research Technician

Evelyn Nguyen
Evelyn Nguyen

Graduate Student

Kathryn M. Tully
Kathryn M. Tully

Graduate Student

Lab Alumni
Eric Gardner
Eric Gardner
Christopher Hulton, BS, MS
Christopher Hulton

Research Scientist at C4 Therapeutic, Watertown, Massachusetts

James Laird
James Laird
Pictured: Benjamin Lok
Benjamin Lok
Linde Miles
Linde Miles
Lab Affilations

Open Positions

Career Opportunities

Apply now

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Charles M. Rudin discloses the following relationships and financial interests:

  • AbbVie
    Provision of Services
  • Amgen
    Provision of Services (uncompensated)
  • Ascentage Pharma
    Provision of Services
  • Astra Zeneca
    Provision of Services
  • Bridge Medicines
    Provision of Services (uncompensated)
  • Celgene
    Provision of Services
  • Chugai Pharmaceuticals
    Provision of Services
  • Daiichi Sankyo
    Provision of Services
  • Elucida Oncology
    Provision of Services (uncompensated)
  • Genentech
    Provision of Services
  • Harpoon Therapeutics, Inc.
    Provision of Services
  • Loxo Oncology
    Provision of Services
  • MORE Health, Inc
    Provision of Services
  • Roche
    Provision of Services
  • SynDevRx Inc
    Provision of Services

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures